在狼中使用类固醇:敌人或盟友
Eugenia Enríquez-Merayo1,2, Maria J Cuadrado2
1Universitary Hospital 12 de Octubre, 28041 Madrid, Spain.
Journal of clinical medicine
|June 10, 2023
概括
葡萄糖皮质类药物有效治疗诸如狼之类的炎症性疾病,但具有显著的副作用. 本综述批判性地检查了它们的好处与治疗相关的伤害.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 葡萄糖皮质类药物是主要治疗炎症和自身免疫性疾病的方法,包括全身性红斑狼 (SLE).
- 虽然在控制症状和降低死亡率方面有效,但葡萄糖皮质类药物与剂量和持续时间限制的副作用有关.
- 系统性红斑狼 (SLE) 是一种复杂的自身免疫性疾病,需要多方面的治疗策略,通常包括皮质类固醇.
研究的目的:
- 批判性地审查现有的关于葡萄糖皮质醇在治疗炎症和自身免疫性疾病中的治疗益处的文献.
- 评估与使用葡萄糖皮质激素相关的副作用和累积损伤的范围,特别是在SLE.
- 在临床实践中提供对葡萄糖皮质类药物的风险益处概况的平衡观点.
主要方法:
- 关于在炎症和自身免疫性疾病中使用葡萄糖皮质醇治疗的已发表研究的综合文献搜索.
- 对有关疗效,副作用和长期损害的证据进行批判性分析.
- 综合发现,以评估葡萄糖皮质类药物的整体影响.
主要成果:
- 葡萄糖皮质类药物表现出强大的抗炎和免疫抑制作用,对于SLE等疾病的急性和慢性治疗至关重要.
- 显著的证据将葡萄糖皮质体的使用与一系列不良影响联系在一起,包括器官损伤,影响患者的长期结果.
- 尽管有新兴的疗法,但葡萄糖皮质类药物仍然是SLE治疗的基石,需要谨慎管理.
结论:
- 葡萄糖皮质类药物在控制免疫激活和炎症方面提供了巨大的好处,但由于相关风险,需要谨慎使用.
- 了解和减轻葡萄糖皮质激素诱导的损害对于优化自身免疫和炎症疾病患者护理至关重要.
- 在使用葡萄糖皮质醇时,平衡治疗优势与潜在危害的方法至关重要.
相关概念视频
Autoimmune Disorders
527
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
527
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Hormones of the Adrenal Glands
2.6K
Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...
2.6K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
161
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
161
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
202
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
202
Antiasthma Drugs: Leukotriene Modifiers
372
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
372


